title: [Clinical significance of tumor markers CYFRA 21-1 and neuron-specific enolase in lung cancer].
authors.forename: N E
authors.initials: NE
authors.lastname: Kushlinskiĭ
authors.forename: N V
authors.initials: NV
authors.lastname: Liubimova
authors.forename: A O
authors.initials: AO
authors.lastname: Lemeshko
authors.forename: A V
authors.initials: AV
authors.lastname: Vasil'ev
authors.forename: M I
authors.initials: MI
authors.lastname: Davydov
mesh_terms: D000230:Adenocarcinoma / Q000175:diagnosis* / Q000473:pathology; D000951:Antigens, Neoplasm / Q000097:blood*; D014408:Biomarkers, Tumor / Q000097:blood*; D018288:Carcinoma, Small Cell / Q000097:blood / Q000175:diagnosis*; D002294:Carcinoma, Squamous Cell / Q000175:diagnosis* / Q000473:pathology; D006801:Humans; D053539:Keratin-19; D007633:Keratins; D008175:Lung Neoplasms / Q000175:diagnosis* / Q000473:pathology; D009367:Neoplasm Staging; D010751:Phosphopyruvate Hydratase / Q000097:blood*
chemical_list: D000951:Antigens, Neoplasm; D014408:Biomarkers, Tumor; D053539:Keratin-19; C102012:antigen CYFRA21.1; D007633:Keratins; D010751:Phosphopyruvate Hydratase